{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:40:21Z","timestamp":1790091621009,"version":"4.0.1"},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":602,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematol Oncol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1002\/hon.2126","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T05:59:07Z","timestamp":1389074347000},"page":"75-79","source":"Crossref","is-referenced-by-count":10,"title":["Clinical analysis of 36 multiple myeloma patients with extramedullary plasmacytoma invasion of the spinal canal"],"prefix":"10.1002","volume":"33","author":[{"given":"Jiajia","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Haematology, Beijing Chaoyang Hospital; Capital Medical University; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Haematology, Beijing Chaoyang Hospital; Capital Medical University; Beijing China"},{"name":"Department of Lymphoma & Myeloma; University of Texas MD Anderson Cancer Center; Houston USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,1,7]]},"reference":[{"key":"10.1002\/hon.2126-BIB0001|hon2126-cit-0001","first-page":"546","article-title":"Multiple myeloma with unusual visceral involvement","volume":"34","author":"Churg","year":"1942","journal-title":"Arch Pathol"},{"key":"10.1002\/hon.2126-BIB0002|hon2126-cit-0002","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/ajcp\/20.10.934","article-title":"Multiple myeloma: lesions of the extra-osseous hematopoietic system","volume":"20","author":"Churg","year":"1950","journal-title":"Am J Clin Pathol"},{"key":"10.1002\/hon.2126-BIB0003|hon2126-cit-0003","first-page":"262","article-title":"Extramedullarylesions in multiple myeloma: review of literature and pathologic studies","volume":"53","author":"Hayes","year":"1952","journal-title":"AMA Arch Pathol"},{"key":"10.1002\/hon.2126-BIB0004|hon2126-cit-0004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1097-0142(196901)23:1<167::AID-CNCR2820230122>3.0.CO;2-0","article-title":"Extraskeletal spread in multiple plasma cell myeloma: a review of 57 autopsied cases","volume":"23","author":"Pasmantier","year":"1969","journal-title":"Cancer"},{"key":"10.1002\/hon.2126-BIB0005|hon2126-cit-0005","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1200\/JCO.1994.12.11.2398","article-title":"Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases","volume":"12","author":"Blade\u00b4","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1002\/hon.2126-BIB0006|hon2126-cit-0006","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2141.1996.5191061.x","article-title":"Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years","volume":"93","author":"Blade\u00b4","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1002\/hon.2126-BIB0007|hon2126-cit-0007","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/10428190802657751","article-title":"The impact of extramedullary disease at presentation in the outcome of myeloma","volume":"50","author":"Wu","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1002\/hon.2126-BIB0008|hon2126-cit-0008","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/annonc\/mdp329","article-title":"Incidence,presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1,003 consecutive patients","volume":"21","author":"Varettoni","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1002\/hon.2126-BIB0009|hon2126-cit-0009","first-page":"1402","article-title":"Clinical features of multiple myeloma invasion of the central nervous system in Chinese patients","volume":"123","author":"Qu","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"10.1002\/hon.2126-BIB0010|hon2126-cit-0010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"The International Myeloma Working Group","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1002\/hon.2126-BIB0011|hon2126-cit-0011","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2307\/2529872","article-title":"Nonparametric estimation of lifetime and disease onset distributions from incomplete observations","volume":"38","author":"Dinse","year":"1982","journal-title":"Biometrics"},{"key":"10.1002\/hon.2126-BIB0012|hon2126-cit-0012","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3","article-title":"Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts","volume":"85","author":"Alexiou","year":"1999","journal-title":"Cancer"},{"key":"10.1002\/hon.2126-BIB0013|hon2126-cit-0013","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1440-1843.2008.01319.x","article-title":"Solitary pleural plasmacytomas manifested as a massive pleural effusion without evidence of monoclonal gammopathy","volume":"13","author":"Feng","year":"2008","journal-title":"Respirology"},{"issue":"suppl12","key":"10.1002\/hon.2126-BIB0014|hon2126-cit-0014","first-page":"32","article-title":"Surgical options in the treatment of myeloma of the spine","volume":"52","author":"Repko","year":"2006","journal-title":"Vnitr Lek"},{"key":"10.1002\/hon.2126-BIB0015|hon2126-cit-0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/10428190310001597964","article-title":"Myeloma of the central nervous system: strong association with unfavorable chromosomal abnormalities and other high-risk disease features","volume":"45","author":"Fassas","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1002\/hon.2126-BIB0016|hon2126-cit-0016","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1200\/JCO.2011.34.9290","article-title":"Soft-tissue plasmacytomas in multiple myeloma: Incidence, mechanisms of extramedullary spread, and treatment approach","volume":"29","author":"Blade","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1002\/hon.2126-BIB0017|hon2126-cit-0017","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/leu.2009.89","article-title":"International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma","volume":"23","author":"Dimopoulos","year":"2009","journal-title":"Leukemia"},{"key":"10.1002\/hon.2126-BIB0018|hon2126-cit-0018","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2009-03-213280","article-title":"F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma","volume":"114","author":"Bartel","year":"2009","journal-title":"Blood"},{"key":"10.1002\/hon.2126-BIB0019|hon2126-cit-0019","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2007-01-067728","article-title":"High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis","volume":"110","author":"Rhee","year":"2007","journal-title":"Blood"},{"key":"10.1002\/hon.2126-BIB0020|hon2126-cit-0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood.V114.22.130.130","article-title":"Thalidomide\/dexamethasone (TD) vs. bortezomib (Velcade)\/Thalidomide\/dexamethasone (VTD) vs. VBMCP\/VBAD\/Velcade as induction regimens prior autologous stem cell transplantation (ASCT) in multiple myeloma (MM): results of a phase III PETHEMA\/GEM trial","volume":"114","author":"Rosinol","year":"2009","journal-title":"Blood"},{"key":"10.1002\/hon.2126-BIB0021|hon2126-cit-0021","first-page":"214","article-title":"Bortezomib combined with other drugs for treating 60 cases of multiple myeloma","volume":"1","author":"Zhong","year":"2009","journal-title":"J Expert Hematol"},{"key":"10.1002\/hon.2126-BIB0022|hon2126-cit-0022","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00277-007-0401-8","article-title":"Bortezomib in combination with thalidomide and dexamethasone- a successful treatment regimen in refractory extramedullary multiple myeloma","volume":"87","author":"Dytfeld","year":"2008","journal-title":"Ann Hematol"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2126","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/hon.2126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T19:38:53Z","timestamp":1625168333000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2126"}},"subtitle":["Multiple myeloma patients with spinal canal invasion"],"short-title":[],"issued":{"date-parts":[[2014,1,7]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1002\/hon.2126","relation":{},"ISSN":["0278-0232"],"issn-type":[{"value":"0278-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,7]]}}}